Cargando…

Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?

BACKGROUND: There is increasing debate about whether the scaled-up investment in HIV/AIDS programs is strengthening or weakening the fragile health systems of many developing countries. This article examines and assesses the evidence and proposes ways forward. DISCUSSION: Considerably increased reso...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Dongbao, Souteyrand, Yves, Banda, Mazuwa A, Kaufman, Joan, Perriëns, Joseph H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556650/
https://www.ncbi.nlm.nih.gov/pubmed/18796148
http://dx.doi.org/10.1186/1744-8603-4-8
_version_ 1782159577327861760
author Yu, Dongbao
Souteyrand, Yves
Banda, Mazuwa A
Kaufman, Joan
Perriëns, Joseph H
author_facet Yu, Dongbao
Souteyrand, Yves
Banda, Mazuwa A
Kaufman, Joan
Perriëns, Joseph H
author_sort Yu, Dongbao
collection PubMed
description BACKGROUND: There is increasing debate about whether the scaled-up investment in HIV/AIDS programs is strengthening or weakening the fragile health systems of many developing countries. This article examines and assesses the evidence and proposes ways forward. DISCUSSION: Considerably increased resources have been brought into countries for HIV/AIDS programs by major Global Health Initiatives. Among the positive impacts are the increased awareness of and priority given to public health by governments. In addition, services to people living with HIV/AIDS have rapidly expanded. In many countries infrastructure and laboratories have been strengthened, and in some, primary health care services have been improved. The effect of AIDS on the health work force has been lessened by the provision of antiretroviral treatment to HIV-infected health care workers, by training, and, to an extent, by task-shifting. However, there are reports of concerns, too – among them, a temporal association between increasing AIDS funding and stagnant reproductive health funding, and accusations that scarce personnel are siphoned off from other health care services by offers of better-paying jobs in HIV/AIDS programs. Unfortunately, there is limited hard evidence of these health system impacts. Because service delivery for AIDS has not yet reached a level that could conceivably be considered "as close to Universal Access as possible," countries and development partners must maintain the momentum of investment in HIV/AIDS programs. At the same time, it should be recognized that global action for health is even more underfunded than is the response to the HIV epidemic. The real issue is therefore not whether to fund AIDS or health systems, but how to increase funding for both. SUMMARY: The evidence is mixed – mostly positive but some negative – as to the impact on health systems of the scaled-up responses to HIV/AIDS driven primarily by global health partnerships. Current scaled-up responses to HIV/AIDS must be maintained and strengthened. Instead of endless debate about the comparative advantages of vertical and horizontal approaches, partners should focus on the best ways for investments in response to HIV to also broadly strengthen the primary health care systems.
format Text
id pubmed-2556650
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25566502008-10-01 Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries? Yu, Dongbao Souteyrand, Yves Banda, Mazuwa A Kaufman, Joan Perriëns, Joseph H Global Health Debate BACKGROUND: There is increasing debate about whether the scaled-up investment in HIV/AIDS programs is strengthening or weakening the fragile health systems of many developing countries. This article examines and assesses the evidence and proposes ways forward. DISCUSSION: Considerably increased resources have been brought into countries for HIV/AIDS programs by major Global Health Initiatives. Among the positive impacts are the increased awareness of and priority given to public health by governments. In addition, services to people living with HIV/AIDS have rapidly expanded. In many countries infrastructure and laboratories have been strengthened, and in some, primary health care services have been improved. The effect of AIDS on the health work force has been lessened by the provision of antiretroviral treatment to HIV-infected health care workers, by training, and, to an extent, by task-shifting. However, there are reports of concerns, too – among them, a temporal association between increasing AIDS funding and stagnant reproductive health funding, and accusations that scarce personnel are siphoned off from other health care services by offers of better-paying jobs in HIV/AIDS programs. Unfortunately, there is limited hard evidence of these health system impacts. Because service delivery for AIDS has not yet reached a level that could conceivably be considered "as close to Universal Access as possible," countries and development partners must maintain the momentum of investment in HIV/AIDS programs. At the same time, it should be recognized that global action for health is even more underfunded than is the response to the HIV epidemic. The real issue is therefore not whether to fund AIDS or health systems, but how to increase funding for both. SUMMARY: The evidence is mixed – mostly positive but some negative – as to the impact on health systems of the scaled-up responses to HIV/AIDS driven primarily by global health partnerships. Current scaled-up responses to HIV/AIDS must be maintained and strengthened. Instead of endless debate about the comparative advantages of vertical and horizontal approaches, partners should focus on the best ways for investments in response to HIV to also broadly strengthen the primary health care systems. BioMed Central 2008-09-16 /pmc/articles/PMC2556650/ /pubmed/18796148 http://dx.doi.org/10.1186/1744-8603-4-8 Text en Copyright © 2008 Yu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Debate
Yu, Dongbao
Souteyrand, Yves
Banda, Mazuwa A
Kaufman, Joan
Perriëns, Joseph H
Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?
title Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?
title_full Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?
title_fullStr Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?
title_full_unstemmed Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?
title_short Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?
title_sort investment in hiv/aids programs: does it help strengthen health systems in developing countries?
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556650/
https://www.ncbi.nlm.nih.gov/pubmed/18796148
http://dx.doi.org/10.1186/1744-8603-4-8
work_keys_str_mv AT yudongbao investmentinhivaidsprogramsdoesithelpstrengthenhealthsystemsindevelopingcountries
AT souteyrandyves investmentinhivaidsprogramsdoesithelpstrengthenhealthsystemsindevelopingcountries
AT bandamazuwaa investmentinhivaidsprogramsdoesithelpstrengthenhealthsystemsindevelopingcountries
AT kaufmanjoan investmentinhivaidsprogramsdoesithelpstrengthenhealthsystemsindevelopingcountries
AT perriensjosephh investmentinhivaidsprogramsdoesithelpstrengthenhealthsystemsindevelopingcountries